ULTRAVATE
Live / Registered — Registered and renewed (as of 01 Nov 2021)
What this means for you
Registered since 18 Jun 1991. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Jun 2021).
Record
- Serial number
- 74024962
- Registration number
- 1647847
- Mark type
- Word mark
- Filed
- 05 Feb 1990
- Published for opposition
- 21 Aug 1990
- Registered
- 18 Jun 1991
- Next maintenance due
- 18 Jun 2021
- Attorney of record
- Craig Kuchii
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals; namely, a topical steroid
Owner
- MICAL PHARMACEUTICALS LLC, SAN DIEGO, CA, US
- SUN PHARMACEUTICAL INDUSTRIES, INC., PRINCETON, NJ, US
- SUN PHARMACEUTICAL INDUSTRIES, INC., PRINCETON, NJ, US
- RANBAXY LABORATORIES, INC., PRINCETON, NJ
- Westwood Pharmaceuticals, Inc., Buffalo, NY, US
- Westwood-Squibb Pharmaceuticals, Inc., Buffalo, NY, US
- Westwood-Squibb Pharmaceuticals, Inc., Buffalo, NY, US
- Westwood Pharmaceuticals Inc., Buffalo, NY, US
- Westwood Pharmaceuticals Inc., Buffalo, NY, US
Prior registrations
Prosecution history
- 28 Jun 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Nov 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Nov 2021 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 01 Nov 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 27 Oct 2021 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 25 Aug 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Jul 2021 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 29 Jul 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Apr 2021 — TEAS SECTION 8 & 9 RECEIVED
- 15 Dec 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Dec 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Dec 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Dec 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Dec 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Jun 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED